Focus on percutaneous short-term ventricular assist devices: joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices - Part 1. Why, how and when percutaneous ventricular assist device support?
28 January 2022, from
European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Doctor A. Chieffo (Milan, IT)
Professor H. Thiele (Leipzig, DE)
Associate Professor G. Tarantini (Padua, IT)
Needs assessment and expected educational outcome
To learn the pathophysiological background of different percutaneous VADs, their indications, and appropriate timing of implantation. Pathophysiology of the different PVADs, their indications, and the appropriate timing in different clinical scenarios will be discussed – i.e cardiogenic shock; STEMI without cardiogenic shock; high risk PCI; and biventricular failure.
After watching this webinar, participants will have learned:
the pathophysiological background of percutaneous VAD;
the indications of percutaneous VAD in different clinical scenarios; and
the timing of support.
This programme is supported by ABIOMED in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.